Skip to main content

Gulf War: NAPS Tablets

Volume 708: debated on Monday 23 February 2009


Asked by

To ask Her Majesty's Government further to the Written Answer by Baroness Taylor of Bolton on 22 January (WA 221–22), whether they will ask the Commission on Human Medicine to review the decision not to include any restriction on co-administration in the instructions for the use of the nerve agent pre-treatment sets (NAPS) tablets, each containing pyridostigmine bromide, used for the troops deployed to the 1990–91 Gulf conflict in the light of the findings of the Congressionally-mandated United States Research Advisory Committee on Gulf War Veterans' Illnesses published on 17 November 2008; and whether they will arrange for a copy of the letter to be sent by Baroness Taylor of Bolton to be published in the Official Report. [HL995]

As set out in the Written Answer of 22 January 2009 (WA 221-222), it is necessary to research our records on the issue prior to providing my noble friend with a substantive reply. We will arrange for the letter to be published in the Official Report, or deposited in the Library of the House as appropriate.